HD Immune’s Team and network

Stefan Bartl, PhD

CEO/CSO

Stefan studied Molecularbiology at the University of Vienna and moved early in his scientific career to the Biotech Industrie focusing on Neuroscience and antibody development. As Group leader of the Neurodegeneration Group at AFFiRiS AG he was responsible for the Huntington’s disease project and he was in charge for the development of a new therapeutic concept in Huntington’s disease targeting mutated HTT protein with monoclonal antibodies.

Lionel Wightman, PhD

CFO/COO

Lionel studied Applied Biology at Imperial College (London) and then obtained a PhD in Virology from Reading University as a Wellcome Trust Prize PhD student. Lionel has worked in different companies in various positions such as CEO, CFO and COO.

International cooperations

UCL, Orlando, FL, USA
Univ Laval, Quebec, CAN
UBC, Vancouver, CAN

HD Immune Partners

The HD Immune office is located in the beautiful City Center of Vienna, Postgasse 8b, 1010 Vienna. The HD Immune Lab is incubated at the Institute of Molecular Biotechnology, Group Wozniak-Knopp at the BOKU (University of natural Resources and Life science) in Vienna.

HD Immune received a pre-seed and seed founding by the Austrian Federal Development and Financing Bank AWS and a founding from the Comet24 program sponsored by ACIB (Austrian Center for Industrial Biotechnology).

HD Immune received an Public Grant from the Wirtschaftsagentur Wien for the execution of in vivo studies of HD Immune’s humanized lead antibodies.